As a first approach we triggered SMO-independent GLI activation in human medulloblastoma cells (DAOY) by RNAi mediated knockdown of SUFU, a critical negative GLI regulator acting downstream of SMO (Figure 3A) [41]. Here, GLI1 is linked to medulloblastoma.